Frankfurt - Delayed Quote EUR
Therma Bright Inc. (JNX.F)
0.0080
0.0000
(0.00%)
At close: April 29 at 8:02:03 AM GMT+2
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Total Revenue
43.8250
26.0700
23.8990
139.4270
3.8830
Cost of Revenue
7.4670
0.6140
--
75.9470
--
Gross Profit
36.3580
25.4560
23.8990
63.4800
3.8830
Operating Expense
2,121.6540
1,260.3280
3,702.4140
5,899.8490
8,597.6440
Operating Income
-2,085.2960
-1,234.8720
-3,678.5150
-5,836.3690
-8,593.7610
Net Non Operating Interest Income Expense
-5.7300
-8.6040
-13.4380
-1.3830
--
Other Income Expense
-1,023.8290
-1,207.8310
-75.8190
-43.3200
-16.5610
Pretax Income
-3,114.8550
-2,451.3070
-3,767.7720
-5,881.0720
-8,610.3220
Net Income Common Stockholders
-3,114.8550
-2,451.3070
-3,767.7720
-5,881.0720
-8,610.3220
Diluted NI Available to Com Stockholders
-3,114.8550
-2,451.3070
-3,767.7720
-5,881.0720
-8,610.3220
Basic EPS
-0.01
-0.01
-0.02
-0.03
-0.04
Diluted EPS
-0.01
-0.01
-0.02
-0.03
-0.04
Basic Average Shares
394,613.4780
318,241.9020
240,269.6040
228,453.6360
199,964.6190
Diluted Average Shares
394,613.4780
318,241.9020
240,269.6040
228,453.6360
199,964.6190
Total Operating Income as Reported
-1,988.6090
-1,135.3580
-3,603.1350
-5,684.6830
-8,535.7830
Total Expenses
2,129.1210
1,260.9420
3,702.4140
5,975.7960
8,597.6440
Net Income from Continuing & Discontinued Operation
-3,114.8550
-2,451.3070
-3,767.7720
-5,881.0720
-8,610.3220
Normalized Income
-2,091.0260
-1,243.4760
-3,691.9530
-5,837.7520
-8,593.7610
Interest Expense
5.7300
8.6040
13.4380
1.3830
--
Net Interest Income
-5.7300
-8.6040
-13.4380
-1.3830
--
EBIT
-3,109.1250
-2,442.7030
-3,754.3340
-5,879.6890
-8,610.3220
EBITDA
-3,012.4380
-2,343.1890
-3,678.9540
-5,728.0030
-8,552.3440
Reconciled Cost of Revenue
7.4670
0.6140
--
75.9470
--
Reconciled Depreciation
96.6870
99.5140
75.3800
151.6860
57.9780
Net Income from Continuing Operation Net Minority Interest
-3,114.8550
-2,451.3070
-3,767.7720
-5,881.0720
-8,610.3220
Total Unusual Items Excluding Goodwill
-1,023.8290
-1,207.8310
-75.8190
-43.3200
-16.5610
Total Unusual Items
-1,023.8290
-1,207.8310
-75.8190
-43.3200
-16.5610
Normalized EBITDA
-1,988.6090
-1,135.3580
-3,603.1350
-5,684.6830
-8,535.7830
7/31/2021 - 5/3/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MASI Masimo Corporation
163.14
-0.55%
TNDM Tandem Diabetes Care, Inc.
16.77
-4.01%
PODD Insulet Corporation
251.27
-3.18%
PEN Penumbra, Inc.
296.91
-0.14%
PRCT PROCEPT BioRobotics Corporation
56.31
+3.97%
SYK Stryker Corporation
370.92
+1.21%
EW Edwards Lifesciences Corporation
76.28
+0.98%
DXCM DexCom, Inc.
71.30
+0.17%
SSII SS Innovations International Inc. Common Stock
10.68
-1.75%
BSX Boston Scientific Corporation
102.74
+0.55%